Panbela Therapeutics, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-03-16: Reporting owner Sargent Robert John; Form 4; Security Series A Preferred Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2015-03-16: Reporting owner Fuhrman David Michael; Form 4; Security Series A Preferred Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-03-16 | Sargent Robert John Director, 10% Owner | 4 | Series A Preferred Stock Non-derivative · Indirect · (m) | P Open market or private purchase of non-derivative or derivative security | +100,060 100,060 owned after | $0.10 | 2015-05-26 | |
| 2015-03-16 | Fuhrman David Michael Director, Officer (President and CEO), 10% Owner | 4 | Series A Preferred Stock Non-derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +100,060 100,060 owned after | $0.10 | 2015-05-19 |